Chromadex Corporation operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chromadex with three other
pharmaceutical manufacturers in North America:
sales of 19.30 million Canadian Dollars [US$15.52 million]
of which 100%
Fitlife Brands Inc
During the year ended December of 2016, sales at
Chromadex were $26.81 million.
increase of 21.8%
versus 2015, when the company's sales were $22.01 million.
This was the third consecutive year of growth at Chromadex.
Sales of Ingredients Segments saw an increase
33.7% in 2016, from
$12.54 million to $16.77 million.
Not all segments of Chromadex experienced an increase in sales in 2016:
sales of Scientific and Regulatory Consulting Segme fell 36.8% to $665,444.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).